FR3025401A1 - ANTI-BOTRYTIS COMPOSITIONS - Google Patents

Abstract

The invention relates to a plant protection composition combining, as active agents, a filamentous fungus of the genus Microdochium, and a second component active against said pathogen of the genus Botrytis, and a method for controlling Botrytis using this composition.

Description

The invention relates to the field of the fight against plant pathogens, by using combinations of biological organisms, such as insects, bacteria, fungi, to get rid of pests of crops, insects or weeds. , to replace or synergize with synthetic pesticides or herbicides. There are 4 main types of bio-control agents.

Auxiliary macro-organisms (or aggressed aggressors) are invertebrates, insects, mites or nematodes used rationally to protect crops against attacks by bio-aggressors. Microorganisms (or the controlled aggressor) are fungi, bacteria and viruses used to protect crops against pests and diseases or to stimulate plant vitality. Chemical mediators include insect pheromones and kairomones. They allow tracking insect pest theft and controlling insect populations by the method of mating disruption and trapping. The natural substances used as bio-control products are composed of substances present in the natural environment and may be of vegetable, animal or mineral origin. Botrytis cinerea is a haploid phytopathogenic fungus of the family Sclerotiniaceae, division Ascomycota. It is responsible for gray mold, a cryptogamic disease affecting several crops of major agronomic interest such as vines, sunflowers, tomatoes and strawberries. Botrytis cinerea attacks a very large number (at least 270 species) of wild plants, including Rosaceae, but also many cultivated plants (Vitaceae, Solanaceae, Cucurbitaceae, Rosaceae and Fabaceae). Viticulture, market gardening, arboriculture and floriculture are affected by gray rot. Thus we can mention tomato, raspberry, strawberry, bean, cucumber, or salad crops (mainly dicotyledonous plants). Among the monocotyledons, grasses are considered insensitive to the difference of bulbs (such as onions). The cultivation of cannabis and flowers is also affected, since roses, gerberas, peonies, carnations, lilies and chrysanthemums are vulnerable to botrytis. Although gray mold tends to attack fruits, all the organs of the plant are potentially susceptible, and the symptoms are varied: wilting of flowers, leaf spots, rot of roots, stems, or fruits. Other species of Botrytis fungus are also plant pathogens (especially Botrytis squamosa, Botrytis allii on the onion). There are a number of fungicidal anti-botrytis treatments. It is thus possible to use polyvalent fungicides, such as phthalimides, or specific fungicides with preventive and curative actions (in particular cyclic imides) or with a single preventive action (especially pyrimethanil). , fludioxonil, fluazinam, or mepanipyrim). Kresoxim-methyl (methyl (aE) -α- (methoxyimino) -2 - [(2-methylphenoxy) methyl] benzeneacetate), Iprodione (3- (3,5-dichlorophenyl) amine) can also be mentioned as a synthetic fungicide. N-isopropyl-2,4-dioxoimidazolidine-1-carboxamide), fenhexamide (N- (2,3-dichloro-4-hydroxyphenyl) -1-methylcyclohexanecarboxamide), or boscalid (3-pyridinecarboxam ide, 2-chloro) -N- (4'chloro [1,1'biphény1] -2-y1)). There are also a number of biological antagonists for Botrytis pathogens, which can be used in the control of Botrytis cinerea. - mushrooms Fusarium spp. and Penicillium claviforme prevent the establishment of B. cinerea on lettuce leaves - the spores of Cladosporium herbarum and Penicillium sp. allowed the control of B. cinerea on glasshouse tomatoes by spraying a suspension of the spores - Inoculated on the flower debris attached to the fruit, C. herbarum effectively controls B. cinerea on the strawberry, protecting the flowers in the flowers. field conditions 30 - Based on an observation of an antagonistic effect of bacteria on B. cinerea on chrysanthemum and beet leaves, the antibiotics produced by these bacteria were studied for their effect. inhibitor on the germination of B. cinerea spores on beet leaves. 3025401 3 - Different species of Trichoderma spp. have been studied for the control of B. cinerea on beans, vines, strawberries and various protected crops. The fungi Ulocladium atrum and Gliocladium roseum have been used to inhibit the germination of conidia and the development of B. cinerea on cyclamen. The applicant has developed for the purpose of placing on the market the fungus Microdochium dimerum strain. L13, which has good efficacy for protecting leaf stripping wounds and leaves of tomato plants against attacks of B. cirenea in protected crops. - Pseudomonas chlororaphis isolate 1-112 and IC1270 isolate of the bacterium Enterobacter agglomerans (fame Serratia plymuthica), both producers of pyrrolnitrin, are also antagonists of B. cinerea. - A number of yeasts (including Pichia and Rhodotorula) and bacteria (including Bacillus and Pseudomonas) have also been reported for their effectiveness in controlling B. cinerea in post-harvest treatment. In particular, mention may be made of Bacillus subtilis strain QST 713, marketed by Bayer Crop Science under the name Serenade® Max. These microorganisms are examples of microorganisms that antagonize Botrytis cinerea.

By "pathogen antagonist agent" is meant a non-deleterious agent (particularly non-pathogenic when this agent is a microorganism) for a plant, capable of limiting the development of said harmful pathogen to the development of the plant. One can easily and quickly determine whether an agent is a pathogen antagonist by carrying out certain simple and rapid experiments: In vitro antagonism by bringing said agent and said pathogen-Antagonism into vivo, by applying said agent to the plant target of the pathogen alone (to verify that it is not itself deleterious to the plant) and in the presence of the pathogen (to evaluate the control capacity thereof).

These experiments are perfectly known and controlled by those skilled in the art and do not require any particular effort to be implemented. The modes of action of biological antagonistic agents of Botrytis are very varied (according to Ajouz, 2009, Ph.D. thesis, Estimation of the resistance potential of Botrytis cinerea to biofungicides). Antibiosis, that is, the production of toxic secondary metabolites for the target pathogen; which can inhibit germination, mycelial growth and / or sporulation of pathogenic agents. Such antibacterial agents have been characterized in strains belonging to various biological control agents (eg Bacillus subtilis, Serratia plymuthica, Pseudomonas fluorescens). Pseudomonas species, for example, produce many antifungal substances: pyoverdine, pyoluteorine, pheazine, pyrrolnitrine, 2,4-diacetylphloroglucinol. The antibiotic gramicidin S secreted by the biological protection agent Brevibacillus brevis inhibits, for example, germination and mycelial growth of B. cinerea. Pyrrolnitrin (3-chloro-4- (2'-nitro-3'-chlorophenyl) -pyrrole) is a broad spectrum antibiotic isolated for the first time in the 1960s from Pseudomonas pyrrocinia which inhibits fungal growth by blocking the respiratory system, and proving effective against B. cinerea.

Hyperparasitism: In the case of hyperparasitism, the antagonist is a parasite that specifically recognizes its target, enters these cells and causes its destruction via the colonization of its organs. Microscopic observation of the interaction between Gliocladium roseum and B. cinerea on raspberry stems showed that protection resulted from colonization of the conidia and hyphae of the pathogen by the antagonist. This mode of action has also been described in Gliocladium catenulatum. Finally, Pythium periplocum has been shown to be a mycoparasite of B. cinerea. - Nutritional competition: B. cinerea is very sensitive to the absence of nutrients: it needs, for example, nutrients of external origin 3025401 5 to ensure the germination of its spores. Certain microorganisms (bacteria, yeasts, filamentous fungi) can thus inhibit the germination of conidia of this pathogen through competition for nutrients such as nitrogen, carbon, or macro- or microelements present in the medium. Reducing the nutrient concentration in the medium generally results in a reduced rate of germinated spores of the pathogen and a slowing of mycelial growth, thereby reducing the number of infections and the expansion of the lesions. The competition for 10 nutrients or space was established for different yeasts applied to apples as post-harvest treatments, such as Candida spp., Cryptococcus laurentii, Sporobolomyces roseus and Candida oleophila. The antagonistic fungus Trichoderma harzianum strain T39 also inhibits conidial germination of B. cinerea by competing for nutrients at early stages of the interaction. Similarly, several bacterial and fungal strains reduce conidial germination of B. cinerea, which reduces the severity of rot symptoms on detached leaves of tomato and bean. The bacterium Pseudomonas sp. For example, amino acids may be used faster than B. cinerea conidia, preventing them from germinating. Interference with Pathogenicity: Biological protection agents may interfere with fungal pathogen factors by inhibiting or degrading certain hydrolytic enzymes (cutinases, pectinases, etc.), as has been observed in T. harzianum T39 . Similarly, the bacterium Bacillus circulans reduces in vitro the pectinolytic activity of B. cinerea and consequently its infection on vines. Certain microorganisms (such as Bacillus pumilus and P. fluorescens) may have an indirect effect on the establishment of pathogenesis by, for example, modifying the pH of the medium. Some oxalic acid-degrading microorganisms, produced by B. cinerea during its interaction with the plant, can protect cucumber, tomato, grapevine and Arabidopsis thaliana against attacks of B. cinerea. 3025401 6 - Modification of surface properties of plant leaves: some bacteria have the ability to change the surface characteristics of plant leaves. This has the effect of hindering the process of attachment and growth of pathogens on the leaves. - Stimulation of the defenses of the plant: The resistance induced in the plant is a mode of action of some biological protection agents. Resistance can be locally induced or it can be systemic.

The induction of systemic resistance in the plant is described in some Trichoderma, Pythium oligandrum and bacteria. In beans, Pseudomonas aeruginosa induces systemic resistance against B. cinerea. Trichoderma harzianum induces resistance against B. cinerea in tomato, lettuce, pepper, beans and tobacco. Various bacterial strains have also been characterized as agents of effective protection against B. cinerea under in vitro conditions (Acinetobacter lwoffii PTA-113 and PTA-152, Bacillus subtilis PTA-271, Pantoea aggiomerans PTA-AF1 and PTAAF2 and Pseudomonas fluorescens PTA -268 and PTA-CT2). Dead cells of certain bacterial or fungal antagonists (T. harzianum, for example) are able to induce local resistance and reduction of gray mold on green beans, tomatoes, peppers and tobacco. Combination of mechanisms of action: In some cases, it may be thought that biological control is the result of several combined modes of action. The most studied case concerns the Trichoderma fungus for which different modes of action have been demonstrated for the same antagonistic strain associating, for example, hyperparasitism and antibiosis. Trichoderma harzianum T39 combines both nutritive competition, interference with the pathogenicity of B. cinerea and resistance induction of the plant. The mode of action of yeast Candida saitoana involved in post-harvest fruit protection combines both nutrient competition and space, 35 hyperparasitism and induction of resistance. Brevibacillus brevis uses both an antibiotic, gramicidin S and a biosurfactant as a mode of action against B. cinerea. In the case of the combination of modes of action in a biological control agent, the precise role and importance of each mode of action in the control of the disease is often not known.

All the microorganisms mentioned above are thus antagonistic agents of a Botrytis pathogen, which can be used in the context of the method and composition described below.

A high number of biological protection agents has thus been identified in the laboratory, but few of these agents have been placed on the market. In France, Serenade®, containing Bacillus subtilis strain QST 713, is registered for use against B. cinerea on the vine (ACTA catalog, 2008, http://e-phy.agriculture.gouv.fr), as well as BOTECTOR ®, marketed by De Sangosse, (Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941) which acts by competition for space and competition for nutrients (http://e-phy.agriculture.gouv.fr/spe/2120082 -10024466.htm). Other products are in the process of being approved, in particular Microdochium dimerum strain L13 (CNCM 1-3141) developed by the company Agrauxine under the name AntiBot®. In particular, this strain has been described by Nicot et al (Potential for microdochium dimerum, a biocontrol agent against Botrytis cinerea, in an integrated protection scheme of greenhouse tomatoes in: Tomato under cover, integrated protection, organic farming (pp 19-23). Presented at Colloquium 25 International, Avignon, FRA (2003-09-17 - 2003-09-19), Paris, FRA: CTIFL), Bardin et al, (Compatibility between biopesticides and powdery mildew and whitefly on tomato, Biological Control, 2008, 46 (3): 476-483), Decognet and Nicot (1999. Effects of fungicides on Fusarium sp., biological control agent of Botrytis cinerea, infections in the perspective of an integrated management of fungal 1999 In: JC Van Lenteren (Editor), IOBC, International Organization for Biological and Integrated Control - West Palearctic Regional Section, Dijon (FRA), Integrated Control in Glasshouses (pp. 49-52), Bulletin OILB SROP, 22 (1) Dijon, FRA: OILB / SROP), Nicot et al (Combined effective microclimate and dose of application of efficacy of biocontrol agents for the protection of pruning wounds on tomatoes against Botrytis cinerea. In: Influence of A-biotic and biotic factors on biocontrol agents (pp. 3025401 73-76). OILB Bulletin SROP, 25 (10). Presented at 7. IOBC Working Group Meeting, Kusadasi, TUR (2002-05-22 - 2002-05-25)). It has also been cited in WO 2013/110591.

The invention is based on the assertion by the Applicant of a synergistic effect when two antagonists of a Botrytis-like pathogen are used in combination, one of these two agents being a Microdochium, in particular a Microdochium dimerum, and in particular the L13 strain. This effect is particularly observed when one and / or the other agent is used at less than the optimum amount of use (or maximum efficacy dose) or the amount recommended in the approvals and authorizations of marketing. It is said that the agents are used at a suboptimal dose. The maximum effectiveness of an anti Botrytis agent is obtained when an improvement in efficacy is not observed following an increase in the dose of the applied product. The maximum efficacy dose is thus defined as the minimum dose for observing maximal efficacy. When an 80% decrease in the symptoms of the disease is observed, the agent is said to be 80% effective. Thus, an agent exhibiting 100% efficacy is such that no symptoms are observed, whereas there is no difference between the symptoms observed on the control plants and the plants treated with the plant. agent when the effectiveness of it is 0%. The efficacy, on whole tomato plants, can be evaluated by following a qualitative and quantitative grid for the presence of symptoms of botrytis. The qualitative scorecard is composed of 2 levels: affected plants (main stem necrotic) and plants not affected by the pathogen (uninfected main stem). The quantitative scoring grid is used to measure the total length of necrosis on the main stem caused by the pathogen. Monitoring the developmental progress of the pathogen over several days makes it possible to perform an analysis of the AUDPC (area under the disease progress curve) type which is also commonly used for efficacy evaluations of fungicidal agents. The data from these notations are then analyzed using a suitable statistical test to determine whether the treatment modalities have an influence on the presence, absence or kinetics of progression of symptoms compared to the control modality.

Such a method of measuring the efficacy and symptoms related to botrytis is described in particular in Bardin, Fargues, and Nicot (2008. Compatibility 3025401 9 between biopesticides used to control gray mold, powdery mildew and whitefly on tomato. : 476-483). Equivalent methods can easily be used to determine the effectiveness of an anti-botrytis agent on other plants.

A suboptimal dose of an anti-botrytis agent is a dose for which efficacy is less than the maximum efficacy, more preferably less than 65%, more preferably less than 55% more preferably less than 50%, more preferably less than 45%, more preferably less than 50% of the maximum efficiency. This suboptimal dose is therefore less than the maximum effectiveness dose. Thus, and as described in the examples, the Applicant has demonstrated that the joint use of the two components, and especially at suboptimal doses, can make it possible to obtain a synergistic effect. Accordingly, it is preferred that the relative amounts of these two components be such as to provide an effect superior to the additive effect, in particular measured by the Colby method.

The method described in the present application is therefore a method of combating or preventing infection with a pathogen of the genus Botrytis in a plant, comprising a step of administering to said plant at least a first component consisting of a microorganism antagonist of said pathogen, said microorganism being a filamentous fungus of the genus Microdochium, and a second active component (antagonist) against said pathogen of the genus Botrytis. The first component is obviously different from the second component. Both components are applied in combination at an "effective" dose, i.e. at a dose for which maximal combination efficacy is observed. In a preferred embodiment, the first component (microorganism of the genus Microdochium) is used in said method at a suboptimal dose. In a preferred embodiment, the second active component against the Botrytis pathogen is applied at a suboptimal dose.

In a preferred embodiment, both components are applied at a suboptimal dose. In these embodiments, it is clear that the suboptimal dose for each agent should be determined relative to the effective dose for that agent alone. In a particular embodiment, no other component having an effect against the pathogen of the genus Botrytis is provided to the plant in the practice of the method.

In a particular embodiment, said method is a "biological method". The term "biological method" is intended to denote a method in which natural elements (in particular natural substances or microorganisms) are applied to crops without chemical or synthetic products (especially small organic molecules) being applied. . The term "chemical or synthetic" is intended to mean any antibiotic or fungicidal agent, produced by chemical synthesis or purification from a microorganism, purified and formulated for application to the plant. In this embodiment, it therefore appears that the second component is not an antagonistic synthetic antifungal of the pathogen of the genus Botrytis and is then preferentially another microorganism antagonist of the pathogen of the genus Botrytis. The method according to the invention is particularly suitable when said pathogen is Botrytis cinerea, but can also be used against other pathogens of the genus Botrytis, as mentioned above. Said second component may be chosen in particular from the Botrytis antagonist microorganisms of the genus Aureobasidium, Ulocladium, Gliocladium, Saccharomyces, Trichoderma (in particular T. harzanium T39) Bacillus or Candida. Thus, in one embodiment, the second component is a filamentous fungus. In one embodiment, said second component is an Aureobasidium pullulans.

In one embodiment, said second component is a Gliocladium catenulatum.

In one embodiment, said second component is an Ulocladium atrum. In another embodiment, said second component is a yeast.

In another embodiment, said second component is a bacterium, preferably of the Bacillus subtilis type, and in particular the QST 713 strain. In another embodiment, said second component is not Bacillus subtilis strain QST 713. In another embodiment, said second component is a synthetic antifungal. In a particular embodiment, this synthetic antifungal is kresoxim-methyl. In a particular embodiment, this synthetic antifungal is iprodione.

In a particular embodiment, this synthetic antifungal is boscalid. In a particular embodiment, this synthetic antifungal is fenhexam ide. In a particular embodiment, this synthetic antifungal is trifloxystrobin. In a preferred embodiment, said first component is a Microdochium dimerum, and in particular the L13 strain whose regulatory development and commercialization are carried out by the Applicant.

As seen above, and as demonstrated in the examples, the Applicant has demonstrated that the joint use of the two components can achieve a synergistic effect. Accordingly, it is preferred that the relative amounts of these two components be such as to provide an effect superior to the additive effect. According to one embodiment of the present invention, the effect obtained is greater than or equal to 10%, preferably 12, more preferably greater than or equal to 15% relative to the expected additive effect for each of the two components. , used alone, as well as calculated according to the method described in the examples. This means that the synergy factor is greater than or equal to 1.1, preferably greater than or equal to 1.12, more preferably greater than or equal to 1.15. The examples show that synergistic factors greater than or equal to 1.5, 2, 5 or more can be observed.

It is easy to determine these relative amounts by methods that can be easily used and practiced by those skilled in the art. Thus, it is possible to prepare some preparations of each of the two components (for example, four or five preparations by varying the amount from 1 to 10 (the value being the usual value for which the efficiency is observed, for example the dose of the registered product, using the component in its pure active ingredient form or in its commercial formulation), and to independently test each of the preparations for its efficacy against Botrytis, then the component mixtures can be tested by varying the concentrations The synergistic effect can be detected, in particular on the basis of the methods described in the examples, Thus, in a usual embodiment, the two components are each applied at a lower dose ( in particular between 1/10 and 1/1) at the dose of the approved product or generally described as having the best efficacy (these are ie for which no improvement in efficacy is observed when the dose is increased), in its pure active ingredient form or its commercial formulation. Thus, for the following products, the effective or approved doses are as follows: Cantus®WG marketed by BASF: Boscalid (500 g / kg) (2-chloro-N (4'-chlorobiphenyl-2-yl) nicotinamide) from the carboxamide family under the nicotinamide group; registered dose: 1.2 kg / ha. Rovral Aqua flo® SC, sold by BASF: Iprodione (500 g / l) (3- (3,5-dichlorophenyl) -Nisopropyl-2,4-dioxoimidazolidin-1-carboxamide) from the chemical family of dicarboximides, group hydantdines; registered dose: 2 l / ha - Teldor® WG, marketed by Bayer CropScience: Fenhexamid (50%) (2 ', 3'-dichloro-4'-hydroxy-1-methylcyclohexanecarboxanilide) of the chemical family Hydroxi-anilides; registered dose: 1.5 kg / ha. Stroby® DF, marketed by BASF: kresoxim-methyl (50%) (methyl (E) -2-methoxyimino-242- (o-tolyloxymethyl) phenyl] acetate) of the family Strobilurins; approved rate 0.2 kg / ha. Natchez® WG, sold by Bayer CropScience: Trifloxystrobin 5 (50%) (methyl (E) -methoxyimino-{(E) -α41- (α, α, α-trifluoro-m-tolyl) ethylidene-aminooxy] -o -tolyl} acetate) of the family of oximinoacetates (strobilurins); registered dose: 0.125 kg / ha - Serenade® Max, available from Bayer CropScience: Subtle Bacillus QST 713 (156.7 g / kg); registered dose 2 kg / ha 10 - Botector®, marketed by DE SANGOSSE: Aureobasidium pullulans (250 g / kg); Approved dose 0.4 kg / ha For other microorganisms, such as yeasts, the theoretical dose would be of the order of 2.5 kg / ha. These include the effective dose for a proprietary strain of yeast (S. cerevisiae) effective on the vine.

In the context of the method or composition described herein, suboptimal doses of each of the components are preferably used. Thus, it is preferable to use a dose of Microdochium dimerum less than or equal to 50% (ie 1/2) of the maximum efficacy dose (DEM) (which is, for strain L13, 2x1012 spores / ha, ie 2, 5 kg / ha of a formulation containing 8 × 10 11 spores / kg), preferably less than or equal to 40% (ie the maximum efficacy dose, preferably less than or equal to 30% (ie about 1/3) of the maximum efficacy dose, more preferably less than or equal to 20% (ie 1/5) of the maximum efficacy dose, even more preferably less than or equal to 10% (ie 1/10) of the dose of maximum efficacy or even less than or equal to 1/12 of the maximum effective dose, the examples show that the first component can be used at a dose equal to 1/15 of the maximum efficacy dose, is of the order of 167 g / ha for a formulation containing 8x1011 spores / kg.

For the second component (Botrytis antagonist), the suboptimal dose that can be used depends, of course, on the nature of this second component. Thus, it is possible to use the following doses: Boscalid (500 g / kg): less than or equal to 1/10, preferably 1/50, preferably 1/100, preferably 1/200, preferably 1 / 500, or 1/1000 of the approved dose (1.2 kg / ha). Iprodione (500 g / l): less than or equal to 1/10, preferably 1/50, preferably 1/100, preferably 1/200, preferably 1/500, or even 1/1000 of the approved dose (2 1 / ha). Fenhexamid (50%): less than or equal to 1/10, preferably 1/50, preferably 1/100, preferably 1/200, preferably 1/500 or 1/1000 of the approved dose (1, 5 kg / ha). Trifloxystrobin (50%): less than or equal to 1/2, preferably 1/5, preferably 1/10, preferably 1/20, preferably 1/50 or 1/100 of the approved dose (0.125 kg / ha). Krésoxim-methyl (50%): less than or equal to 1/10, preferably 1/50, preferably 1/100, preferably 1/200, preferably 1/500 or 1/1000 of the approved dose (0.2 kg / ha). - Bacillus subtilis QST 713 (156.7 g / kg): it is possible to use the approved dose (2kg / ha) or a dose less than or equal to 1/2, or less than or equal to 1/5 of the approved dose. - Saccharomyces cerevisiae (proprietary strain, named 1202, 20 with an effective effect on botrytis on grapevine) (100%): we can use the envisaged dose (2.5 kg / ha) or a dose less than or equal to 1 / 10, preferably 1/50, preferably 1/100, preferably 1/200, preferably 1/500 or 1/1000 of the approved dose.

In one embodiment, both components are applied simultaneously, within the same process slurry. Thus, the operator will prepare a composition for treating the plant, simultaneously or successively incorporating at least one Microdochium microorganism and another Botrytis-like pathogen antagonist with one or more excipients. These excipients are known in the art, and are, in particular, wettable powders or granules. In another embodiment, the two components are not applied simultaneously, but are applied separately (one after the other). These two distinct applications must, however, be carried out at short notice, that is to say in a range of less than 48 hours, preferably less than 26 hours, preferably less than 24 hours, preferably less than 16 hours, more preferably less than 12 hours. By performing these separate applications, the first applied component can be allowed to begin its effect before the other component. Of course, the first component to be added may be the microdochium microorganism, and the second component to be added may be the second component listed above (the other antagonist of the Botrytis pathogen). In another embodiment, the first component to be added is the second component listed above (the other antagonist agent of the Botrytis pathogen) and the second component to be added is the microdochium microorganism. In a preferred embodiment, both components are applied to said plant during a period of risk of developing Botrytis (whether it is a period of risk of plant contamination or risk of developing symptoms after contamination). The period of risk can thus be determined for the vine. Botrytis contaminations take place at three key periods of vine development, late flowering (stage A): spores can not enter the bay, but contamination can be through wounds associated with falling flower hoods . Closure of the cluster (stage B): the spores still can not penetrate the berries, but they can be enclosed between the grapes and on the stalks. They constitute an inoculum that expects favorable conditions to develop. Véraison (stage C): From the veraison, the receptivity of the berries to this disease is strong, the film of the bay is weakened and sugars are synthesized.

The germinating spores of the botrytis enter the bay causing enzymatic defense reactions and the release of the fungal laccase. Once the berries are receptive, they can be contaminated in two ways: the first, by the mycelium already installed on plant debris, stuck between two berries or locked inside the cluster. The second way of contamination of the berries is through spores produced by the fungus, which are then transported into the plot by rain and wind. The production of 3025401 16 spores, and therefore the contamination by this second route, is carried out at an optimum temperature of 15 to 20 ° C, in the presence of free water or relative humidity greater than 90% for at least 15 hours. The period of risk of developing botrytis symptoms therefore starts from veraison.

5 The risk period for vegetable and ornamental crops is determined by the following conditions: Botrytis appreciates moderate temperatures, and has an optimal development between 18 and 20 ° C, especially in the presence of moisture, during rainy periods, in a humid atmosphere under a greenhouse or under a frame. Poor aeration is also a factor favoring, for example, in cultures in a confined environment or in the case of dense vegetation. In a preferred embodiment, the components are sprayed onto the aerial parts of the plants. The treatment slurry can be prepared in the following way: The two components, presented in the form of dispersible granules, wettable powders or liquid formulations, are poured directly into the tank of a sprayer half filled with water. agitation system being in operation to obtain good suspension. Then it is completed by adding water to the tank by adding what is necessary for the application, while maintaining agitation. The slurry can be used at the volumes / ha usually applied to crops (100 to 1000 1 / ha).

The method can be carried out on any plant susceptible to infection by a Botrytis, and in particular Botrytis cinerea. As seen above, this pathogen has a broad spectrum of hosts. The method is particularly suitable for cultivated plants, and especially when said plants are selected from the group consisting of tomato, lettuce, strawberry, melon, grapevine (producing table grapes or wine grapes), and fruit trees producing fruits with kernel (cherries, apricot peaches, brugnons and nectarines, plums). It can also be applied in horticulture.

The invention also relates to a phytopharmaceutical composition containing, as active agents, a first component consisting of a microorganism antagonist of a pathogen of the genus Botrytis, said microorganism being a filamentous fungus of the genus Microdochium, and a second active component against said pathogen, the two active agents being different.

In a preferred embodiment, the first component, the second component or both components are present in this composition at a suboptimal dose or concentration. Preferably this composition contains only these two components as active agents, i.e. there are no other active agents against Botrytis in the composition. In another embodiment, this composition may contain other active agents against Botrytis. In a particular embodiment, however, this composition does not contain any synthetic molecule (that is, synthesized per se in the laboratory, or isolated in the laboratory from a microbial agent). The composition is then called "biological" or "biocontrol". It may thus contain one or more other biocontrol agents as described above, and in particular one or more other microorganisms (yeast, filamentous fungus, or bacteria).

This composition may however contain adjuvants or excipients (in particular wettable powders or granules). This composition is intended for the implementation of the method described above. It is therefore preferably suitable for spray administration on the aerial parts of plants.

Furthermore, the amounts of the first component (microorganism antagonist of a pathogen of the genus Botrytis, said microorganism being a filamentous fungus of the genus Microdochium, in particular a Microdochium dimerum), and the second component active against said pathogen are chosen to allow a effect superior to the additive effect. The relative amounts of each agent thus make it possible to obtain a synergy of effectiveness. We have seen above how to determine these relative quantities, as well as the quantities to be used, in this composition. They are also chosen so that one or the other or both are smaller than the quantities that would be used for the agents alone. Various Botrytis pathogen antagonists usable in this composition have been listed above, although it is preferred that it be a synthetic antifungal, a bacterium (especially Bacillus subtilis) or a yeast.

In this composition, said microdochium and said second agent may be mixed in the same container or placed in two separate containers, the mixing being carried out during the administration (joint spraying of the two components).

The method of making such a composition, which comprises the simultaneous or sequential incorporation of at least one Microdochium and another antagonist agent of a Botrytis pathogen with one or more, has also been described above. excipients.

The examples therefore clearly show that a microorganism of the genus Microdochium, antagonist of a pathogen of the genus Botrytis, and in particular a Microdochium dimerum, may be used to restrict the doses of another antagonist agent of this pathogen, and / or to prepare a composition for the control or treatment of Botrytis, and / or to potentiate the effect of this other antagonist agent of this pathogen, especially when used at suboptimal doses. This use can be carried out as part of a method of treating a plant with said other agent (adding Microdochium dimerum and reducing the dose of this other agent, while maintaining the observed activity with the dose of this other agent when used alone), or in the context of a preparation of a plant protection composition (decrease in the amount of this other agent in the composition, for the purpose of treating the same number of plants or the same surface) . The use of a microorganism of the genus Microdochium in combination with another Botrytis pathogen antagonist compound is therefore contemplated to increase control or treatment efficacy against said Botrytis pathogen. DESCRIPTION OF THE FIGURES FIG. 1: FIG. 1 shows examples of synergy between Microdochium dimerum L13 and other pesticides for the control of Botrytis cinerea. Column 1: antagonist product used; column 2: Active ingredient; column 3: Registered dose (maximum effective dose); column 4: Measured efficacy of the pesticide (suboptimal applied dose); Column 5: Measured efficacy of Microdochium dimerum L13 (suboptimal applied dose); column 6: Expected efficacy of the mixture at suboptimal doses (Colby formula); column 7: 3025401 19 Measured efficacy of the mixture at suboptimal doses; Column 8: Synergistic Factor (SF) Figure 2: Figure 2 exemplifies the observed synergistic effect. A. Untreated control indicator; B. M. dimerum L13 (1/15 DEM); C. Cantus® (Boscalid) (DEM 1/1000); D. M. dimerum L13 (1/15 DEM) and Cantus® (1/1000 DEM). Figure 3: Figure 3 exemplifies the observed synergistic effect. A. Untreated control indicator; B. M. dimerum L13 (1/15 DEM); C. Rovral Aqua flo® (Iprodione) (DEM 1/1000); D. M. dimerum L13 (1/15 DEM) and Rovral Aqua flo® (1/1000 DEM).

Figure 4: Figure 4 exemplifies the observed synergistic effect. A. Untreated control indicator; B. M. dimerum L13 (1/15 DEM); C. Stroby® (kresoxim-methyl) (1/1000 DEM); D. M. dimerum L13 (1/15 DEM) and Stroby® (1/1000 DEM). Figure 5: Figure 5 exemplifies the observed synergistic effect. A. Untreated control indicator; B. M. dimerum L13 (1/15 DEM); C. Teldor® (Fenhexamid) (1/1000 DEM); D. M. dimerum L13 (1/15 DEM) and Teldor® (1/1000 DEM). Figure 6: Figure 6 exemplifies the observed synergistic effect. A. Untreated control indicator; B. M. dimerum L13 (1/15 DEM); C. S. cerevisiae (proprietary strain 12012) (2.5 kg / ha); D. M. dimerum L13 (1/15 DEM) and S. cerevisiae (2.5 kg / ha).

EXAMPLES Modes of operation and principles Definition Synergy: Unexpected effectiveness of a combination of active substances, greater than the sum of the activities of the active substances applied separately, and this clearly differentiated from an additivity effect which is defined as the level expected effectiveness of the combination of active substances. Demonstration method of the existence of a synergy between two active substances or products.

The mathematical method used to identify the efficacy synergies of two plant protection products used together is derived from the Colby formula (Gowing, 1960 (Comments on tests of herbicide mixtures, Weeds 8: 379-391), Colby, 1967 (Calculating synergistic and antagonistic responses of herbicide combinations Weeds 15 (1967), pp. 20-22) Soller and Wedemeir, 2012 35 (Prediction of synergistic multi-compound mixtures - A generalized Colby approach, Crop Protection, Vol 42, 2012, 180 -185).

According to this method, the efficiencies of separately applied plant protection products are used to calculate the expected efficacy of the products used in combination.

The expected efficacy of a combination of two products is calculated as follows: P1 and P2 are the observed efficiencies of two products at a certain application dose (in%), the effectiveness being the reduction of symptoms caused by a pathogen relative to an untreated control, the expected efficiency E of the combination of the two products, in the absence of interaction between them, is given by the formula E = P1 + P2 Where P1 corresponds to the level of effectiveness of protection of the product 1 evaluated individually and P2 corresponds to the protection effectiveness level of the product 2 evaluated individually. According to this method, the expected efficiency of a combination of two products does not correspond to the simple sum of the individual efficiencies, but to a lower value. Colby's calculation is based on the notion that a simple addition neglects the possibility that a certain proportion of the pathogen is controlled simultaneously by the two products of the mixture. This problem is solved by subtraction P1P2 / 100. Expected Where SF is the Synergy Factor; Emesured is the measured efficacy of the combination of active substances and Expected is the expected efficiency of the association.

The Synergy SF Factor is interpreted as follows: A SF ratio greater than or less than 1 indicates a deviation from the product-independent action hypothesis, demonstrating that the two products biologically work together. If SF> 1 the interaction is synergistic, if SF <1 131132 100 In order to determine the presence of synergies, the ratio SF (synergy factor) between the observed efficiency of the combination (Emeasurée) and the expected efficiency 25 (Expected ) of the combination is calculated as follows: SF = measured 3025401 21 the interaction is antagonistic. A ratio of 1 indicates no interaction between products. In short: SF> 1: Presence of Synergy 5 SF = 1: Presence of SF Additivity <1: Presence of an antagonistic interaction (less efficiency than expected) Procedure to determine the effectiveness of a single product or The examples presented below were conducted using whole tomato plants grown under controlled conditions favorable to the development of Botrytis cinerea. The observed efficiencies were measured against a set of control plants that received no antifungal protection treatment. In planta test procedure: Each treatment modality consists of 5 to 10 whole tomato plants at the 4 to 5 leaf stage. 3 leaves of each one of the plants are sectioned with scissors, this stripping is performed similarly to the stripping performed during the commercial production of tomatoes. A drop of 5 μl of Botrytis cinerea spore suspension calibrated at 2 × 10 6 or 8 × 10 6 spores per ml is deposited on each petiole of the severed leaves (either 10,000 or 80,000 spores per petiole). Then the different treatments are applied to the petioles of the severed leaves, while control control plants are treated with pure water.

Preparation of the treatment solution and treatment The treatment slurry is prepared in the following manner: Each component (or both components), in the form of dispersible granules, wettable powders or liquid formulations, is poured directly into the the tank of a sprayer half filled with water, the stirring system being operated to obtain a good suspension.

Thereafter, the volume of water required for application in the tank is added while maintaining agitation. The slurry can be used at the volumes / ha usually applied to crops (100 to 1000 1 / ha). In the examples, an equivalent slurry of 100L / ha was used. The set of plants is incubated at 19 ° / 20 ° C., with a relative humidity of the order of 99/100% and a photoperiod of 16 hours per day.

10 Efficacy Evaluation After one week of incubation, each plant is scored according to a qualitative and quantitative grid for the presence of Botritys cinerea symptoms. The qualitative scoring grid is composed of 2 levels: affected plants 15 (main stem collapsed) and plants not affected by the pathogen (main stem unscathed) The quantitative scoring grid makes it possible to measure the total length of the necroses on the main stem caused by the pathogen.

The data resulting from these notations are then analyzed using a suitable statistical test to determine whether the treatment modalities have an influence on the presence or absence of the symptoms compared to the control modality.

Because of the high efficacy against Botrytis cinerea of the antagonist products tested, synergies are sought at suboptimal application levels, which allows partial control of the disease symptoms and makes the data from the notations suitable for use within the Colby Formula.

Figure 1 shows examples of synergy between Microdochium dimerum L13 and other pesticides for control of Botrytis cinerea. Each row of the table represents the results obtained for an independent experiment. It is observed that the measured efficiencies may vary at the same application rates of the product.

Claims (3)

REVENDICATIONS1. A method of combating or preventing infection with a pathogen of the genus Botrytis in a plant, comprising a step of administering to said plant at least one first component consisting of a microorganism antagonizing said pathogen, said microorganism being a filamentous fungus of the genus Microdochium, and a second component active against said pathogen of the genus Botrytis, characterized in that at least one of the two components is applied at a suboptimal dose. Method according to claim 1, characterized in that said pathogen is Botrytis cinerea. A method according to claim 1 or 2, characterized in that said second component is selected from the group consisting of yeasts, synthetic antifungals, bacteria, and other biocontrol microorganisms antagonistic to said pathogen of the genus Botrytis. Method according to one of claims 1 to 3, characterized in that said second component is a yeast, in particular of the Candida albicans or Saccharomyces cerevisiae type. Method according to one of claims 1 to 3, characterized in that said second component is a Bacillus subtilis bacterium. Method according to one of claims 1 to 3, characterized in that said second component is a synthetic antifungal selected from the group consisting of kresoxim-methyl, iprodione, boscalid, fenhexamide and trifloxystrobin. Method according to one of claims 1 to 5, characterized in that it is a biological method, in which no other active synthetic agent against Botrytis is provided to the plant. 10 2. 15 3. 204. 5. 25 6. 30 7. 35 3025401 24 8. 5 9. 10. 11. 12. 13. 14. 30 15. 35 Method according to one of claims 1 to 7, characterized in that the two components are applied in relative amounts to obtain an effect greater than the additive effect. Method according to one of claims 1 to 8, characterized in that the two components are each applied at a suboptimal dose. Method according to one of claims 1 to 9, characterized in that the two components are applied simultaneously, within the same treatment slurry. Method according to one of Claims 1 to 9, characterized in that the two components are applied one after the other in a time interval of less than 48 hours. Method according to one of claims 1 to 11, characterized in that the two components are applied to said plant during a period of risk of Botrytis development. Method according to one of claims 1 to 12, characterized in that the components are applied by spraying on the aerial parts of the plants. Method according to one of claims 1 to 13, characterized in that said plants are selected from the group consisting of tomato, lettuce, strawberry, melon, vine (producing table grape or wine grape), and fruit trees producing fruit with kernel (cherries, peaches apricots, brugnons and nectarines, plums). A phytopharmaceutical composition containing, as active agents, a first component consisting of a microorganism antagonizing said pathogen, said microorganism being a filamentous fungus of the genus Microdochium, and a second component active against said pathogen of the genus Botrytis, wherein the amounts of the two components are chosen to allow an effect superior to the additive effect. 16. Compositions according to claim 15, characterized in that said second component is selected from the group consisting of yeasts, synthetic antifungals, bacteria, and other biocontrol microorganisms antagonistic to said pathogen of the genus Botrytis. 17. Composition according to claim 15 or 16, characterized in that said first component and said second component are mixed in the same container or placed in two separate containers. 18. Composition according to any one of claims 15 to 17, characterized in that it also contains excipients such as wettable powders or granules. 19. A method of manufacturing a composition according to any one of claims 15 to 18 comprising the incorporation simultaneously or successively of at least a first component consisting of a microorganism antagonist said pathogen, said microorganism being a filamentous fungus of genus Microdochium, and a second component active against said pathogen of the genus Botrytis. 20. Use of a microorganism of the genus Microdochium to decrease the dose of an antagonist compound of a Botrytis pathogen. 21. Use of a microorganism of the genus Microdochium in combination with another antagonist compound of a Botrytis pathogen to increase control or treatment efficacy against said Botrytis pathogen.